1. Home
  2. QUIK vs HELP Comparison

QUIK vs HELP Comparison

Compare QUIK & HELP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo QuickLogic Corporation

QUIK

QuickLogic Corporation

HOLD

Current Price

$21.86

Market Cap

211.8M

Sector

Technology

ML Signal

HOLD

HELP

Cybin Inc. Common Stock

N/A

Current Price

$4.60

Market Cap

214.5M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
QUIK
HELP
Founded
1988
N/A
Country
United States
Canada
Employees
51
50
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
211.8M
214.5M
IPO Year
1997
N/A

Fundamental Metrics

Financial Performance
Metric
QUIK
HELP
Price
$21.86
$4.60
Analyst Decision
Buy
Strong Buy
Analyst Count
1
2
Target Price
$11.00
$51.50
AVG Volume (30 Days)
425.9K
567.2K
Earning Date
05-12-2026
07-01-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$20,112,000.00
N/A
Revenue This Year
$75.17
N/A
Revenue Next Year
$16.04
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.80
$3.76
52 Week High
$24.33
$8.55

Technical Indicators

Market Signals
Indicator
QUIK
HELP
Relative Strength Index (RSI) 56.84 53.98
Support Level $17.30 $4.32
Resistance Level $23.61 $4.75
Average True Range (ATR) 1.88 0.30
MACD -0.25 0.08
Stochastic Oscillator 61.18 91.00

Price Performance

Historical Comparison
QUIK
HELP

About QUIK QuickLogic Corporation

QuickLogic Corp is a fabless semiconductor company developing programmable logic semiconductor technologies, including embedded Field Programmable Gate Array (eFPGA) intellectual property (IP) and specialized FPGA devices. Its product offerings include the eFPGA IP licensing business and associated professional services, as well as a range of FPGA silicon products, including EOS, ArcticLink III, PolarPro 3, PolarPro II, PolarPro, and Eclipse II products, among others. The company's customers come from various markets, including aerospace and defense, industrial and infrastructure systems, data processing and computing platforms, and certain embedded and edge computing applications. Geographically, it generates maximum revenue from North America and the rest from Asia Pacific and Europe.

About HELP Cybin Inc. Common Stock

Helus Pharma Inc, the commercial operating name of Cybin Inc, is a clinical-stage pharmaceutical company focused on developing proprietary neuroactive compounds, referred to as NSAs, which are synthetic molecules designed to target serotonin pathways. The company's programs are aimed at treating mental health conditions such as depression and anxiety. Its pipeline includes HLP003, which is in clinical development for the adjunctive treatment of depressive disorder, and HLP004, which is in clinical development for generalized anxiety disorder. The company also conducts research on additional investigational compounds.

Share on Social Networks: